These results validate the previous reports by us and others that ERRα exhibits an up-regulation pattern in advanced prostate cancer and also its usefulness as a poor prognostic marker for prostate cancer 18-20, 22. This evidence concerns the gene ESRRA and Familial prostate cancer.